ECONSALUD Archivos

Economía de la Salud

ECONSALUD@LISTSERV.REDIRIS.ES

Opciones: Vista Clásica

Use Proportional Font
Mostrar las partes HTML
Esconda cabeceras de correo

Tema: [<< Primero] [< Prev] [Siguiente >] [Último >>]

Print Responder
Received: by LISTSERV.REDIRIS.ES (LISTSERV-TCP/IP release 16.0) with spool id 14650713 for [log in para visualizar]; Thu, 11 Feb 2021 19:46:25 +0100 from lsv.rediris.es (lsv.rediris.es [130.206.1.61]) by listserv.rediris.es (Postfix) with ESMTP id 7BC1F2350D; Thu, 11 Feb 2021 19:46:25 +0100 (CET)
Content-Type: text/plain; charset="UTF-8"
Date: Thu, 11 Feb 2021 19:46:25 +0100
Reply-To: Economía de la Salud <[log in para visualizar]>
Content-Transfer-Encoding: quoted-printable
Emisor: AES ECONSALUD <[log in para visualizar]>
Sender: Economía de la Salud <[log in para visualizar]>
Mime-Version: 1.0
Parts/Attachments: text/plain (15 lines)
8-week Specialization Course in Economic Evaluation of Pharmaceuticals and Medical Technologies
 
The  aim of this course, taught entirely online by Prof. Jaume Puig-Junoy, is to introduce the participant to the basic and fundamentals aspects of the main techniques and instruments used in the economic evaluation of pharmaceuticals and medical technologies
 
This course is useful for any health non health professional related with health economics and pharmacoeconomics, the pharmaceutical industry and drug management, either in public or private institutions.

The online methodology allows for self-paced learning and flexibility, as it is designed to be completely compatible for full time professionals.
 
After successful completion of the course, there is the possibility of 6 ECTS recognition to the Master in Health Economics and Pharmacoeconomics, with more than 20 editions that attest to this program's success and solidity, and ranked in the TOP 4 worldwide by EdUniversal Ranking.
 
100% online in English
3 March 2021 – 4 May 2021
Tuition fee: 900 euros
More information here: https://www.bsm.upf.edu/en/economic-evaluation-pharmaceuticals-medical-technologies-basics

ATOM RSS1 RSS2